Shanghai Fosun Pharmaceutical : RESIGNATION OF NON-EXECUTIVE DIRECTOR (H SHARES)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

上 海 復 星 醫 藥（ 集 團 ）股 份 有 限 公 司

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02196)

RESIGNATION OF NON-EXECUTIVE DIRECTOR

On 17 January 2020, the board (''Board'') of directors (''Directors'') of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (the ''Company'') received a resignation letter from Mr. Liang Jianfeng (''Mr. Liang''), who reported to the Board to resign as a non-executive Director due to the change in work arrangement. In accordance with the articles of association of the Company, the resignation of Mr. Liang shall become effective from 17 January 2020.

Mr. Liang has confirmed that there is no disagreement between him and the Board during his term of office and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.

The Board hereby expresses its gratitude to Mr. Liang for his valuable contribution during his term of office.

By order of the Board

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

Chen Qiyu

Chairman

Shanghai, People's Republic of China

17 January 2020

As at the date of this announcement, the executive directors of the Company are Mr. Chen Qiyu, Mr. Yao Fang and Mr. Wu Yifang; the non-executive directors of the Company are Mr. Xu Xiaoliang, Mr. Wang Can and Ms. Mu Haining; and the independent non-executive directors of the Company are Mr. Jiang Xian, Dr. Wong Tin Yau Kelvin, Ms. Li Ling and Mr. Tang Guliang

• for identification purposes only